Evolution of the Average Target: IMPACT Therapeutics, Inc

Evolution of the Average Target - IMPACT Therapeutics, Inc

Evolution of the Target Price: IMPACT Therapeutics, Inc

Evolution of the Target Price - IMPACT Therapeutics, Inc

Changes in Analyst Recommendations: IMPACT Therapeutics, Inc

f7bf9c031bf01738e9b.0qmFryDRZo3cBySP51Ua2MitQT5QF5oRe1PXJXcrXCI.tcjd7XriKaDxfmfC1RRPi53gK10BXqNpTxqkV0dgG2Ok4s7eSrgRy4UqVw~431f857631292c7102d503e594344219

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - - +205.72%
+32.59%
+28.07%
+10.26%
+8.34%
+15.58%
+38.17%
+38.53%
+31.23%
+4.99%
Average +41.35%
Weighted average by Cap. +23.50%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
8.854CNY
Average target price
27.28CNY
Spread / Average Target
+208.07%
High Price Target
27.28CNY
Spread / Highest target
+208.07%
Low Price Target
27.28CNY
Spread / Lowest Target
+208.07%

Analyst Consensus Detail

Analyst consensus - IMPACT Therapeutics, Inc

Consensus revision (last 18 months)

Consensus revision (last 18 months) - IMPACT Therapeutics, Inc
  1. Stock Market
  2. Stocks
  3. 7630 Stock
  4. Consensus IMPACT Therapeutics, Inc